Clinical and Translational

Better Knowledge for Better Care with QIAGEN and N-of-One: Precision medicine for any cancer assay on any platform

502 views
May 29, 2019
For NGS cancer testing, keeping pace with new discoveries is a serious bottleneck. Valuable information can go undetected due to inadequate mining and interpretation mechanisms. These are called "knowledge blind spots" and can have significant clinical consequences. QIAGEN is the world leader in aggregating genetic disease knowledge resources. For the past 20 years, we have partnered with clinical testing labs throughout the world to manually curate genetic evidence across all human genes (23,000). N-of-One’s approach combines expert curation, the insights of oncology experts, and a proprietary technology and knowledgebase, MarkerMine™, to provide curated, high-quality, and actionable clinical interpretation of molecular tests. Join us for an informative webinar about both clinical interpretation solutions.

Interested in learning more?

Click here


Speakers: Dan Richards, Ph.D., Vice President of Biomedical Informatics at QIAGEN Sheryl Elkin, Ph.D., Chief Scientific Officer of N-of-One, Inc.Less

Related videos

Clinical and Translational

Managing Multiple Biomarker Therapeutic Development

131 views September 12, 2019

For the past two decades, the paradigm in the field has been “one biomarker,...

Clinical and Translational

Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow

34 views October 30, 2019

BRCA1/BRCA2 genes represent the best examples for our current understanding...

Clinical and Translational

Fast tracking clinical NGS testing with QIAGEN Clinical Informatics services

39 views October 15, 2019

Discover a simpler and faster approach to implementing clinical NGS...

Clinical and Translational

The Human Gene Mutation Database: Empowering a Generation of Geneticists for Precision Medicine

857 views April 10, 2019

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive...